Literature DB >> 20024105

Pyridine and pyrimidine analogs of acetaminophen as inhibitors of lipid peroxidation and cyclooxygenase and lipoxygenase catalysis.

Tae-Gyu Nam1, Susheel J Nara, Irène Zagol-Ikapitte, Thomas Cooper, Luca Valgimigli, John A Oates, Ned A Porter, Olivier Boutaud, Derek A Pratt.   

Abstract

Herein we report an investigation of the efficacy of pyridine and pyrimidine analogs of acetaminophen (ApAP) as peroxyl radical-trapping antioxidants and inhibitors of enzyme-catalyzed lipid peroxidation by cyclooxygenases (COX) and lipoxygenases (LOX). In inhibited autoxidations we find that ApAP, the common analgesic and antipyretic agent, is a very good antioxidant with a rate constant for reaction with peroxyl radicals (k(inh) = 5 x 10(5) M(-1) s(-1)) that is higher than many widely-used phenolic antioxidants, such as the ubiquitous butylated hydroxytoluene (BHT). This reactivity is reduced substantially upon incorporation of nitrogen into the phenolic ring, owing to an increase in the O-H bond dissociation enthalpy of pyridinols and pyrimidinols with respect to phenols. Incorporation of nitrogen into the phenolic ring of ApAP was also found to decrease its efficacy as an inhibitor of prostaglandin biosynthesis by ovine COX-1 (oCOX-1). This is explained on the basis of an increase in its oxidation potential and its reduced reactivity as a reducing co-substrate of the peroxidase protoporphyrin. In contrast, the efficacy of ApAP as an inhibitor of lipid hydroperoxide biosynthesis by soybean LOX-1 (sLOX-1) increased upon incorporation of nitrogen into the ring, suggesting a different mechanism of inhibition dependent on the acidity of the phenolic O-H which may involve chelation of the catalytic non-heme iron atom. The greater stability of the 3-pyridinols and 5-pyrimidinols to air oxidation as compared to phenols allowed us to evaluate some electron-rich pyridinols and pyrimidinols as inhibitors of oCOX-1 and sLOX-1. While the pyridinols had the best combination of activities as antioxidants and inhibitors of oCOX-1 and sLOX-1, they were found to be more toxic than ApAP in preliminary assays in human hepatocellular carcinoma (HepG2) cell culture. The pyrimidinols, however, were up to 17-fold more reactive to peroxyl radicals and up to 25-fold better inhibitors of prostaglandin biosynthesis than ApAP, with similar cytotoxicities to HepG2 cells at high levels of exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20024105      PMCID: PMC2873786          DOI: 10.1039/b912528k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  58 in total

Review 1.  New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases.

Authors:  David M Aronoff; John A Oates; Olivier Boutaud
Journal:  Clin Pharmacol Ther       Date:  2006-01       Impact factor: 6.875

Review 2.  Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases.

Authors:  Carol A Rouzer; Lawrence J Marnett
Journal:  Chem Rev       Date:  2003-06       Impact factor: 60.622

3.  On the interaction of some catechol derivatives with the iron atom of soybean lipoxygenase.

Authors:  J R Galpin; L G Tielens; G A Veldink; J F Vliegenthart; J Boldingh
Journal:  FEBS Lett       Date:  1976-10-15       Impact factor: 4.124

4.  Antioxidant properties of some chemicals vs their influence on cyclooxygenase and lipoxidase activities.

Authors:  Z Duniec; J Robak; R Gryglewski
Journal:  Biochem Pharmacol       Date:  1983-07-15       Impact factor: 5.858

5.  Mechanism of acetaminophen inhibition of cyclooxygenase isoforms.

Authors:  M Ouellet; M D Percival
Journal:  Arch Biochem Biophys       Date:  2001-03-15       Impact factor: 4.013

6.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.

Authors:  S P Crouch; R Kozlowski; K J Slater; J Fletcher
Journal:  J Immunol Methods       Date:  1993-03-15       Impact factor: 2.303

7.  Inhibition of prostaglandin H2 synthases by salicylate is dependent on the oxidative state of the enzymes.

Authors:  David M Aronoff; Olivier Boutaud; Lawrence J Marnett; John A Oates
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

Review 8.  Acetaminophen-induced hepatotoxicity.

Authors:  Laura P James; Philip R Mayeux; Jack A Hinson
Journal:  Drug Metab Dispos       Date:  2003-12       Impact factor: 3.922

9.  Reductive inactivation of soybean lipoxygenase 1 by catechols: a possible mechanism for regulation of lipoxygenase activity.

Authors:  C Kemal; P Louis-Flamberg; R Krupinski-Olsen; A L Shorter
Journal:  Biochemistry       Date:  1987-11-03       Impact factor: 3.162

Review 10.  Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

Authors:  Kathleen S Montine; Joseph F Quinn; Jing Zhang; Joshua P Fessel; L Jackson Roberts; Jason D Morrow; Thomas J Montine
Journal:  Chem Phys Lipids       Date:  2004-03       Impact factor: 3.329

View more
  14 in total

1.  Nickel-Catalyzed [2+2+2] Cycloaddition of Diynes and Cyanamides.

Authors:  Ryan M Stolley; Michael T Maczka; Janis Louie
Journal:  European J Org Chem       Date:  2011-07

2.  Rational Design of Novel Pyridinol-Fused Ring Acetaminophen Analogues.

Authors:  Roman V Shchepin; Wei Liu; Huiyong Yin; Irene Zagol-Ikapitte; Taneem Amin; Byeong-Seon Jeong; L Jackson Roberts; John A Oates; Ned A Porter; Olivier Boutaud
Journal:  ACS Med Chem Lett       Date:  2013-08-08       Impact factor: 4.345

Review 3.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

4.  Acetaminophen inhibits cytochrome c redox cycling induced lipid peroxidation.

Authors:  Huiyong Yin; Aurélia Vergeade; Qiong Shi; William E Zackert; Katherine C Gruenberg; Magdalena Bokiej; Taneem Amin; Weizhen Ying; Tina S Masterson; Sandra S Zinkel; John A Oates; Olivier Boutaud; L Jackson Roberts
Journal:  Biochem Biophys Res Commun       Date:  2012-05-23       Impact factor: 3.575

5.  An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome.

Authors:  Libin Xu; Zeljka Korade; Dale A Rosado; Wei Liu; Connor R Lamberson; Ned A Porter
Journal:  J Lipid Res       Date:  2011-03-14       Impact factor: 5.922

Review 6.  Research developments in the syntheses, anti-inflammatory activities and structure-activity relationships of pyrimidines.

Authors:  Haroon Ur Rashid; Marco Antonio Utrera Martines; Adriana Pereira Duarte; Juliana Jorge; Shagufta Rasool; Riaz Muhammad; Nasir Ahmad; Muhammad Naveed Umar
Journal:  RSC Adv       Date:  2021-02-03       Impact factor: 3.361

7.  Orally active multi-functional antioxidants delay cataract formation in streptozotocin (type 1) diabetic and gamma-irradiated rats.

Authors:  James Randazzo; Peng Zhang; Jun Makita; Karen Blessing; Peter F Kador
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

8.  Acetaminophen: beyond pain and Fever-relieving.

Authors:  Eric R Blough; Miaozong Wu
Journal:  Front Pharmacol       Date:  2011-11-09       Impact factor: 5.810

9.  Acetaminophen Overdose Enhances Early Cholangiocarcinoma in Opisthorchiasis Hamsters.

Authors:  Pranee Sriraj; Thidarut Boonmars; Ratchadawan Aukkanimart; Atchara Artchayasawat; Glenn N Borlace; Panaratana Ratanasuwan; Benjamabhorn Pumhirunroj
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

10.  3-Pyridinols and 5-pyrimidinols: Tailor-made for use in synergistic radical-trapping co-antioxidant systems.

Authors:  Luca Valgimigli; Daniele Bartolomei; Riccardo Amorati; Evan Haidasz; Jason J Hanthorn; Susheel J Nara; Johan Brinkhorst; Derek A Pratt
Journal:  Beilstein J Org Chem       Date:  2013-12-04       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.